Skip to content

Effect of mint gel on prevention of pressure ulcer

Clinical Trial of comparison effect of mint gel and placebo gel on incidence rate of pressure ulcer in hospitalized patients with head injury in neurosurgical ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402098665N3
Enrollment
70
Registered
2014-03-07
Start date
2014-03-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decubitus ulcer. Decubitus ulcer and pressure area

Interventions

Intervention 1: After patient arrival to ICU in test group, 3 times a day (once per shift) used a layer of mint gel on skin of areas are at risk for pressure ulcers such as pelvic and bone prominences
Prevention
Placebo
After patient arrival to ICU in test group, 3 times a day (once per shift) used a layer of mint gel on skin of areas are at risk for pressure ulcers such as pelvic and bone prominences along routine n
After patient arrival to ICU in control group, 3 times a day (once per shift) used a layer of placebo gel on skin of areas are at risk for pressure ulcers such as pelvic and bone prominences along rou

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Hospitalization in intensive care due to head injury; Patient's transfer to the intensive care unit with endotracheal tube; absence of any underlying disease such as cardiovascular, lung, kidney, diabetes and other chronic disease; No history of allergy to plants in the mint family; The lack of pressure ulcers on arrival; Glasgow Coma Scale (GCS) 8 or less on arrival; Patients with multiple trauma if they do not have restrictions on postural changes are enrolled. Exclusion Criteria: Death or transfer of the patient within 48 hours; patient's unwillingness to cooperate a few days after admission; Sensitivity to mint gel; inflammation of mucous membrane (the site of gel application); refusing for continuing study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pressure ulcer. Timepoint: Once a day. Method of measurement: Checklists prepared of Bruden tool, present clinical status and National Pressure Ulcer Advisor Panel guide.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Babamohamadi

Semnan University of Medical Sciences

babamohamadi@sem-ums.ac.ir+98 23 1335 4192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026